Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator

Gene Therapy

Volumn 4, Issue 5, 1997, Pages 432-441

  Wang, Y ^a   Xu, J ^a   Pierson, T ^a   O'Malley, B W ^a   Tsai, S Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Gene activation and repression; Inducible system; RU486

Indexed keywords

CHIMERIC PROTEIN; DNA BINDING PROTEIN; ETOPOSIDE; MIFEPRISTONE; NERVE GROWTH FACTOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RAT; YEAST;

ANIMALIA; EUKARYOTA; MAMMALIA;

EID: 0031001166     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300402     Document Type: Article

References (40)

1. McKnight SL. Transcription revisited: a commentary on the 1995 Cold Spring Harbor Laboratory meeting, 'Mechanisms of Eukaryotic Transcription'. Genes Dev 1996; 10: 367-381.
2. Mayo KE, Warren R, Palmiter RD. The mouse metallothionein-1 gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 1982; 29: 99-108.
3. Nover L (ed). Heat Shock Response. CRC Press: Boca Raton, 1991, pp 167-220.
4. Baim SB, Labow MA, Levine AJ, Shenk T. A chimeric mammalian transactivator based on the lac represser that is regulated by temperature and isopropyl β-D-thiogalactoside. Proc Natl Acad Sci USA 1991; 88: 5072-5076.
5. Braselmann S, Graninger F, Busslinger M. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc Natl Acad Sci USA 1993; 90: 1657-1661.
6. Lee F, Mulliagen R, Berg P, Ringold G. Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids. Nature 1981; 294: 228-232.
7. Figge J et al. Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by E. coli lac repressor in monkey cells. Cell 1988; 52: 713-722.
8. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
9. Gossen M et al. Transcriptional activation by tetracyclines in mammalian cells Science 1995; 268: 1766-1769.
10. No D, Yao T-P, Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996; 93: 3346-3351.
11. Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW. A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 1994; 91: 8180-8184.
12. Vegeto E et al. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor Cell 1992; 69: 703-713.
13. Wegner M, Drolet DW, Rosenfeld MG. POU-domain proteins, structure and function of developmental regulators. Curr Opin Cell Biol 1993; 5: 488-498.
14. Gerber H-P et al. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 1994; 263: 808-811.
15. Seipel K, Georgiev O, Gerber H-P, Schaffner W. C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively. Nucleic Acids Res 1993; 21: 5609-5615.
16. Witzgall R et al. Kid-1, a putative renal transcription factor, regulation during ontogeny and in response to ischemia and toxic injury. Mol Cell Biol 1993; 13: 1933-1942.
17. Witzgall R et al. The Krüppel-associated Box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc Natl Acad Sci USA 1994; 91: 4514-4518.
18. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424-2428.
19. Goodrich JA, Tjian R. TBP-TAF complexes: selectivity factors for eukaryotic transcription. Curr Opin Cell Biol 1994; 6: 403-409.
20. Pugh BF. Mechanisms of transcription complex assembly. Curr Opin Cell Biol 1996; 8: 303-311
21. Oñate SA, Tsai SY, Tsai M-J, O'Malley BW Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270: 1354-1357.
22. Kamei Y et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996; 85: 403-114.
23. Hörlein AJ et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 1995; 377: 397-404.
24. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995; 377: 454-457.
25. Xu J et al The extreme C-terminus of progesterone receptor contains a transcriptional represser domain that functions through a putative corepressor. Proc Natl Acad Sci USA 1996; 93-12195-12199.
26. Goodrich JA et al. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell 1993; 75: 519-530.
27. Kuhl DPA, Caskey CT. Trinucleotide repeats and genome variation. Curr Opin Gen Dev 1993; 3: 404-407.
28. Ross CA, McInnis MG, Margolis RL, Li S-H. Genes with triplet repeats: candidate mediators of neuropsychiatric disorders. Trends Neurosci 1993; 16: 254-260.
29. Ashley CT Jr, Warren ST. Trinucleotide repeat expansion and human disease. Ann Rev Genet 1995; 29: 703-728.
30. Servadio A et al. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet 1995; 10: 94-98.
31. Yazawa I et al. Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain. Nat Genet 1995; 10: 99-103.
32. Trottier Y et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 1995; 10: 104-110.
33. Burke JR et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996; 2: 347-350.
34. Kingston RE, Bunker CA, Imbalzano AN. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev 1996; 10: 905-920.
35. Baniahmad A et al. The tau4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol 1995; 15: 76-86.
36. Sauer F et al. Control of transcription by Krüppel through interactions with TFIIB and TFIIEβ. Nature 1995; 375: 162-164.
37. Margolin J et al. Krüppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci USA 1994; 91: 4509-4513.
38. Deuschle U, Meyer WK-H, Thiesen H-J. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol 1995; 15: 1907-1914.
39. Wang Y, DeMayo F, Tsai SY, O'Malley BW. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 1997 (in press).
40. Wang Y, O'Malley BW, Tsai SY. Inducible system designed for future gene therapy. In: Tuan R (ed). Methods in Molecular Biology, Vol. 63: Recombinant Proteins. Detection and Isolation Protocols. Humana Press: New Jersey, 1997 (in press).